Log In
Print
BCIQ
Print
Print this Print this
 

Single-Dose Sufentanil NanoTab (ARX-04)

  Manage Alerts
Collapse Summary General Information
Company AcelRx Pharmaceuticals Inc.
DescriptionSublingual formulation of sufentanil, a synthetic mu-opioid analgesic
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat moderate to severe acute pain; Treat moderate to severe pain following ambulatory abdominal surgery
Regulatory Designation

Partner

U.S. Department of Defense


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today